» Articles » PMID: 36164985

Characterization of Circular RNAs with Advanced Sequencing Technologies in Human Complex Diseases

Overview
Publisher Wiley
Date 2022 Sep 27
PMID 36164985
Authors
Affiliations
Soon will be listed here.
Abstract

Circular RNAs (circRNAs) are one category of non-coding RNAs that do not possess 5' caps and 3' free ends. Instead, they are derived in closed circle forms from pre-mRNAs by a non-canonical splicing mechanism named "back-splicing." CircRNAs were discovered four decades ago, initially called "scrambled exons." Compared to linear RNAs, the expression levels of circRNAs are considerably lower, and it is challenging to identify circRNAs specifically. Thus, the biological relevance of circRNAs has been underappreciated until the advancement of next generation sequencing (NGS) technology. The biological insights of circRNAs, such as their tissue-specific expression patterns, biogenesis factors, and functional effects in complex diseases, namely human cancers, have been extensively explored in the last decade. With the invention of the third generation sequencing (TGS) with longer sequencing reads and newly designed strategies to characterize full-length circRNAs, the panorama of circRNAs in human complex diseases could be further unveiled. In this review, we first introduce the history of circular RNA detection. Next, we describe widely adopted NGS-based methods and the recently established TGS-based approaches capable of characterizing circRNAs in full-length. We then summarize data resources and representative circRNA functional studies related to human complex diseases. In the last section, we reviewed computational tools and discuss the potential advantages of utilizing advanced sequencing approaches to a functional interpretation of full-length circRNAs in complex diseases. This article is categorized under: RNA Evolution and Genomics > Computational Analyses of RNA RNA in Disease and Development > RNA in Disease.

Citing Articles

Circular RNA TAF4B targeting MFN2 accelerates cell growth in bladder cancer through p27 depression and AKT activation.

Zhang X, Xu J, Zhuang G, Wang Y, Li X, Zhu X Front Immunol. 2024; 15:1477196.

PMID: 39430741 PMC: 11486711. DOI: 10.3389/fimmu.2024.1477196.


Hsa_circ_0001278 Facilitates Colorectal Cancer Progression Sponging miR-338-5p and Regulating AMOTL1 Expression.

Ge H, Yan Y, Wang H, Bian J, Deng Z, Su X Comb Chem High Throughput Screen. 2023; 28(1):99-109.

PMID: 38018210 DOI: 10.2174/0113862073265207231108052536.


Circular RNAs: characteristics, functions, mechanisms, and potential applications in thyroid cancer.

Wu M, Yuan H, Zou W, Xu S, Liu S, Gao Q Clin Transl Oncol. 2023; 26(4):808-824.

PMID: 37864677 DOI: 10.1007/s12094-023-03324-0.


CircUTRN24/miR-483-3p/IGF-1 Regulates Autophagy Mediated Liver Fibrosis in Biliary Atresia.

Liu D, Wu Z, Gao J, Mei Q, Zhang X, Wang B Mol Biotechnol. 2023; 66(6):1424-1433.

PMID: 37369954 DOI: 10.1007/s12033-023-00802-2.


Discovery of dysregulated circular RNAs in whole blood transcriptomes from cystic fibrosis patients - implication of a role for cellular senescence in cystic fibrosis.

Salinas E, Macauley V, Keeling K, Edwards Y J Cyst Fibros. 2023; 22(4):683-693.

PMID: 37142522 PMC: 10947771. DOI: 10.1016/j.jcf.2023.04.021.